Updated:
Avego Bioscience Capital
Avego Bioscience Capital is a venture capital firm. It has invested $416 million across three deals. Its focus areas include biotechnology and manufacturing.
Overview
Avego Bioscience Capital is a venture capital firm. It has invested $416 million across three deals. Its focus areas include biotechnology and manufacturing.
General information
Firm type
Healthcare/Biotechnology
Year founded
2015
Location
Region
Europe
Country
United Kingdom
City
Alpharetta
Corporate office
London, United Kingdom
Additional offices
Boston · New York · Dallas · White Plains · Philadelphia · Los Angeles · San Francisco · Chicago
Sector focus
Frequently asked questions
Where does Avego Bioscience Capital maintain offices?
The firm lists offices in London, Boston, New York, Dallas, White Plains, Philadelphia, Los Angeles, San Francisco, and Chicago, per its public registrations. This transatlantic footprint is unusually broad for a specialist bioscience investor.
Does Avego Bioscience Capital invest in therapeutics or digital health?
The firm's mandate covers both therapeutics and digital health, operating at the intersection of biology and computation. Its presence in San Francisco supports exposure to computational biology and AI-driven drug discovery startups, while its East Coast and Texas offices connect it to traditional biotech and clinical research hubs.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: